Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Identifying potentially cost effective chronic care programs for people with COPD

Authors L M G Steuten, K M M Lemmens, A P Nieboer, H JM Vrijhoef

Published 22 December 2008 Volume 2009:4 Pages 87—100

DOI https://doi.org/10.2147/COPD.S3047

Review by Single-blind

Peer reviewer comments 2

L M G Steuten1, K M M Lemmens2, A P Nieboer2, H JM Vrijhoef3

1Maastricht University Medical Centre, School for Care and Public Health Research, Department of Health, Organisation, Policy and Economics, Maastricht, The Netherlands; 2Erasmus University Medical Centre, Institute of Health Policy and Management, Rotterdam, The Netherlands; 3Maastricht University Medical Centre, School for Care and Public Health Research, Department of Integrated Care, Maastricht, The Netherlands

Objective: To review published evidence regarding the cost effectiveness of multi-component COPD programs and to illustrate how potentially cost effective programs can be identified.

Methods: Systematic search of Medline and Cochrane databases for evaluations of multi-component disease management or chronic care programs for adults with COPD, describing process, intermediate, and end results of care. Data were independently extracted by two reviewers and descriptively summarized.

Results: Twenty articles describing 17 unique COPD programs were included. There is little evidence for significant improvements in process and intermediate outcomes, except for increased provision of patient self-management education and improved disease-specific knowledge. Overall, the COPD programs generate end results equivalent to usual care, but programs containing ≥3 components show lower relative risks for hospitalization. There is limited scope for programs to break-even or save money.

Conclusion: Identifying cost effective multi-component COPD programs remains a challenge due to scarce methodologically sound studies that demonstrate significant improvements on process, intermediate and end results of care. Estimations of potential cost effectiveness of specific programs illustrated in this paper can, in the absence of ‘perfect data’, support timely decision-making regarding these programs. Nevertheless, well-designed health economic studies are needed to decrease the current decision uncertainty.

Keywords: chronic care management, COPD, cost-effectiveness, review

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized clinical trial

Dias FD, Sampaio LMM, da Silva GA, Dantas Gomes ELF, Nascimento ESP, Santos Alves VL, Stirbulov R, Costa D

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:537-544

Published Date: 5 November 2013

Improving adherence with inhaler therapy in COPD

Suzanne C Lareau, Barbara P Yawn

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:401-406

Published Date: 24 November 2010

Long-term therapy in COPD: any evidence of adverse effect on bone?

Arnulf Langhammer, Siri Forsmo, Unni Syversen

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:365-380

Published Date: 30 September 2009

ICS and COPD: Time to clear the air

Paul A Ford, Richard EK Russell, Peter J Barnes

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:289-290

Published Date: 31 July 2009

Management of invasive aspergillosis in patients with COPD: rational use of voriconazole

Florence Ader, Anne-Lise Bienvenu, Blandine Rammaert, et al.

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:279-287

Published Date: 24 July 2009

Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD

Yvette RBM van Gestel, Sanne E Hoeks, Don D Sin, Henk Stam, Frans W Mertens, Jeroen J Bax, Ron T van Domburg, Don Poldermans

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:177-183

Published Date: 8 May 2009

Targeted treatment of advanced and metastatic breast cancer with lapatinib

Brendan Corkery, Norma O’Donovan, John Crown

OncoTargets and Therapy 2008, 1:21-34

Published Date: 16 September 2008